Barrett & Company, Inc. Ark Genomic Revolution ETF (De Transaction History
Barrett & Company, Inc.
- $292 Billion
- Q3 2025
A detailed history of Barrett & Company, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Barrett & Company, Inc. holds 25 shares of ARKG stock, worth $672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$672
Previous $609,000
13.96%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
296Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio